TY - JOUR
T1 - Polymorphisms in the FcεRIβ promoter region affecting transcription activity
T2 - A possible promoter-dependent mechanism for association between FcεRIβ and atopy
AU - Nishiyama, Chiharu
AU - Akizawa, Yushiro
AU - Nishiyama, Makoto
AU - Tokura, Tomoko
AU - Kawada, Hiroshi
AU - Mitsuishi, Kouichi
AU - Hasegawa, Masanari
AU - Ito, Tomonobu
AU - Nakano, Nobuhiro
AU - Okamoto, Atsushi
AU - Takagi, Atsushi
AU - Yagita, Hideo
AU - Okumura, Ko
AU - Ogawa, Hideoki
PY - 2004/11/15
Y1 - 2004/11/15
N2 - The β subunit of the high-affinity IgE receptor (FcεRI) plays an important role in IgE-mediated allergic reactions as an amplifier for cell surface expression and signal transduction of FcεRI. FcεRIβ is presumed to be one of the genes linked with atopic diseases. However, the validity of the associations previously found between single nucleotide polymorphisms (SNPs) in FcεRIβ and atopic diseases is questionable. In the present study, we found correlation between the SNP of FcεRIβ at +6960A/G, resulting in a Glu237Gly amino acid substitution, and the cell surface expression level of FcεRI on blood basophils, although it has been shown that the Glu237Gly mutation itself does not affect the surface expression or function of FcεRI. We additionally found four SNPs in the promoter region of FcεRIβ, among which -426T/C and -654C/T were tightly linked with +6960A/G. Reporter plasmids carrying the -426C and -654T promoter displayed higher transcriptional activity than those carrying the -426T and -654C promoter. We found that transcription factor YY1 preferentially bound and transactivated the -654T promoter. Furthermore, expression of FcεRI β-chain mRNA in basophils from individuals who have the minor heterozygous genotype was significantly higher than that of the major homozygous genotype. These results suggest that the SNPs in the FcεRIβ promoter are causally linked with atopy via regulation of FcεRI expression.
AB - The β subunit of the high-affinity IgE receptor (FcεRI) plays an important role in IgE-mediated allergic reactions as an amplifier for cell surface expression and signal transduction of FcεRI. FcεRIβ is presumed to be one of the genes linked with atopic diseases. However, the validity of the associations previously found between single nucleotide polymorphisms (SNPs) in FcεRIβ and atopic diseases is questionable. In the present study, we found correlation between the SNP of FcεRIβ at +6960A/G, resulting in a Glu237Gly amino acid substitution, and the cell surface expression level of FcεRI on blood basophils, although it has been shown that the Glu237Gly mutation itself does not affect the surface expression or function of FcεRI. We additionally found four SNPs in the promoter region of FcεRIβ, among which -426T/C and -654C/T were tightly linked with +6960A/G. Reporter plasmids carrying the -426C and -654T promoter displayed higher transcriptional activity than those carrying the -426T and -654C promoter. We found that transcription factor YY1 preferentially bound and transactivated the -654T promoter. Furthermore, expression of FcεRI β-chain mRNA in basophils from individuals who have the minor heterozygous genotype was significantly higher than that of the major homozygous genotype. These results suggest that the SNPs in the FcεRIβ promoter are causally linked with atopy via regulation of FcεRI expression.
UR - http://www.scopus.com/inward/record.url?scp=8444234617&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.173.10.6458
DO - 10.4049/jimmunol.173.10.6458
M3 - Article
C2 - 15528387
AN - SCOPUS:8444234617
SN - 0022-1767
VL - 173
SP - 6458
EP - 6464
JO - Journal of Immunology
JF - Journal of Immunology
IS - 10
ER -